Renhe Pharmacy Co (SZSE:000650) ROCE % : 8.12% (As of Sep. 2024)

View and export this data going back to 1996. Start your Free Trial

What is Renhe Pharmacy Co ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Renhe Pharmacy Co's annualized ROCE % for the quarter that ended in Sep. 2024 was 8.12%.

Renhe Pharmacy Co ROCE % Historical Data

The historical data trend for Renhe Pharmacy Co's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Renhe Pharmacy Co ROCE % Chart

Renhe Pharmacy Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

ROCE %

Get a 7-Day Free Trial

19.89

17.38

17.87

15.37

13.66

Renhe Pharmacy Co Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
ROCE %	Get a 7-Day Free Trial															17.69	2.37	15.60	15.92	8.12

Renhe Pharmacy Co ROCE % Calculation

Renhe Pharmacy Co's annualized ROCE % for the fiscal year that ended in Dec. 2023 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	899.205	/	( ( (7634.773 - 1164.511)	+	(7444.681 - 751.012) )	/ 2 )
	=	899.205	/	( (6470.262	+	6693.669)	/ 2 )
	=	899.205	/	6581.9655
	=	13.66 %

Renhe Pharmacy Co's ROCE % of for the quarter that ended in Sep. 2024 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Sep. 2024 )		(Q: Jun. 2024 )		(Q: Sep. 2024 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Sep. 2024 )		(Q: Jun. 2024 )		(Q: Sep. 2024 )
	=	566.716	/	( ( (8039.79 - 969.909)	+	(7635.385 - 749.584) )	/ 2 )
	=	566.716	/	( ( 7069.881	+	6885.801 )	/ 2 )
	=	566.716	/	6977.841
	=	8.12 %

(1) Note: The EBIT data used here is four times the quarterly (Sep. 2024) EBIT data.

Renhe Pharmacy Co (SZSE:000650) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Renhe Pharmacy Co ROCE % Related Terms

Thank you for viewing the detailed overview of Renhe Pharmacy Co's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

Renhe Pharmacy Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Renhe Pharmacy Co Ltd (SZSE:000650) » Definitions » ROCE %

Traded in Other Exchanges

N/A

Address

No. 998, Honggutan Road, Greenland Central Plaza, 18th Floor, Yuanchuang International, Zone B, Honggutan New District, Jiangxi Province, Nanchang, CHN, 330038

Website

http://www.renheyaoye.com

Renhe Pharmacy Co Ltd is a China-based company engaged in the production and sale of Chinese and Western medicine, bulk drugs and health-related products. The products include oral solid preparations, oral liquid preparations, large-volume injections, small-volume injections, topical lotions, tinctures, suppositories, ointments and other pharmaceutical products and health-related products. The company's main products are Renhe Kelik, Youkadan series, Fu Yan Jie series, Dahuoluo capsules, shiny eye drops, Qinghuo capsules, Zhengwei capsules and others.

Executives

Yang Xiao	Director
Kang Zhi Hua	Supervisors
Mei Qiang	Directors, executives
Yang Wen Long	Director

Renhe Pharmacy Co Headlines

No Headlines